Eagle Pharmaceuticals, Inc. (EGRX) Investor Notice: Robbins LLP Reminds Investors of Class Action Fi
SAN DIEGO--(BUSINESS WIRE)--$EGRX #EaglePharmaceuticalsInc--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) securities between August 8, 2023 and November 28, 2023. Eagle Pharma...